TickerInside
Connect your agent Copies a setup prompt for your AI assistant

IVOG holdings and overlap

View as Markdown What changed
IVOGVanguard S&P Mid-Cap 400 Growth ETFMid-Cap Growth, Vanguard, 245 positions
Last close, 2026-09-04
$141.40 +0.23%
52-week range 114 to 148
Largest position
TWLO
1.65% of the fund, Twilio Inc. Class A
Positions
245
13.9% in the ten largest
Cost per year
0.10%
$10 a year on $10,000
Assets
$1.8B
the whole fund, all share classes
Return, 3 years
+56.5%
cumulative, total return
Worst fall
-23.0%
peak to trough, 3 years, weekly closes

What does IVOG hold, as of its issuer file of 2026-07-31?

IVOG holds 245 positions as of the issuer file dated 2026-07-31. The three largest are Twilio Inc. Class A at 1.65%, TechnipFMC plc at 1.58% and Curtiss-Wright Corp. at 1.48%; no ten names make up even 15% of it.

RankCompanyWeightWeight bar
1 TWLO Twilio Inc. Class A 1.65%
2 FTI TechnipFMC plc 1.58%
3 CW Curtiss-Wright Corp. 1.48%
4 ATI Allegheny Technologies Inc. 1.41%
5 NVT nVent Electric plc 1.37%
6 P Pure Storage Inc. Class A 1.34%
7 OKTA Okta Inc. 1.31%
8 XPO XPO Logistics Inc. 1.3%
9 UTHR United Therapeutics Corp. 1.21%
10 THC Tenet Healthcare Corp. 1.21%
11 WWD Woodward Inc. 1.19%
12 CRS Carpenter Technology Corp. 1.13%
13 RBA RB Global Inc. 1.13%
14 ROKU Roku Inc. 1.05%
15 STRL Sterling Construction Co. Inc. 1.01%
16 ITT ITT Inc. 0.97%
17 RBC RBC Bearings Inc. 0.96%
18 NBIX Neurocrine Biosciences Inc. 0.93%
19 ILMN Illumina Inc. 0.92%
20 MTSI MACOM Technology Solutions Holdings Inc. 0.91%
21 MTZ MasTec Inc. 0.89%
22 RGLD Royal Gold Inc. 0.89%
23 JAZZ Jazz Pharmaceuticals plc 0.88%
24 FN Fabrinet 0.86%
25 BWXT BWX Technologies Inc. 0.85%

Issuer file 35 days old on 2026-09-04, against a median of 1 across the funds with a page. Every one of the 245 positions with its weight is in the fund's JSON file. See which other ETFs hold TWLO, and at what weight.

What does IVOG duplicate?

The fund nearest to IVOG is MDYG: the two hold 94.7% of their weight in common, in the 245 companies both own, and 100.0% of IVOG itself is also held there. Owning IVOG alongside the funds at the top of this table means holding mostly the same companies twice. IVOG is close to contained in MDYG.

FundOverlap by weightOf IVOG held thereOf that fund in IVOGCompanies in bothOverlap bar
MDYG 94.7% 100.0% 99.6% 245
SPMD 65.1% 100.0% 66.8% 245
IVOO 65.0% 100.0% 66.6% 245
MDY 64.8% 100.0% 66.8% 245
QVMM 60.7% 84.4% 64.4% 203
RFG 59.8% 63.0% 100.0% 100
SMMD 49.3% 81.1% 25.2% 222
VBK 43.0% 71.4% 43.9% 146
XMMO 38.7% 38.7% 89.6% 65
ISCG 33.5% 58.0% 34.3% 170
RWK 31.1% 97.5% 35.7% 240
VB 29.3% 99.5% 29.3% 243

From each issuer's latest file. Check IVOG against any fund in the ETF overlap calculator · how overlap is measured.

What adds something different to IVOG?

SPLV shares 0% of weight with IVOG and its weekly returns correlate with it at 0.54 over three years. The table lists the covered funds with the least in common with IVOG, least shared weight first and, among equals, lowest correlation.

Cost, returns and risk

Expense ratio0.10%
Dividend yield0.55%
Total return, 1 year18.4%
Total return, 3 years cumulative56.5%
Total return, 5 years cumulative45.6%
Volatility, annualised17.3%
Worst fall, 3 years-23.0%
Beta against SPY, 3 years of weekly returns1.0
Weight in the ten largest positions13.9%
Largest single position1.7%
Assets, whole fund across share classes$1.8B

Expense ratio, yield and assets are reference data; every other figure is computed here from weekly closes.

How it moves with the market

AgainstCorrelation, 3 yearsCovariance, annualised, in percent squared
SPY0.84often in step208
QQQ0.74often in step248

Weekly total returns. What the bands mean · why the covariance is printed.

Year by year

YearTotal return
202617.6%
20257.3%
202415.6%
202317.4%
2022-19.1%

One year

IVOG 118 SPY 118
2025-09-122026-09-04
IVOG rebased to 100 a year ago, weekly closes, prices through 2026-09-04.

Where to go next

Holdings from the issuer file published 2026-07-31. Prices through 2026-09-04. How every figure here is produced. Measurements, not investment advice.